Does induction treatment increase the risk of morbidity and mortality after pneumonectomy? A multicentre case-matched analysis

European Journal of Cardio-thoracic Surgery

Volumn 37, Issue 3, 2010, Pages 535-539

  Refai, Majed ^a   Brunelli, Alessandro ^a   Rocco, Gaetano ^b   Ferguson, Mark K ^c   Fortiparri, Sergio N ^d   Salati, Michele ^a   La Rocca, Antonello ^b   Kawamukai, Kenji ^d  

^a Azienda Ospedaliera Umberto I   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c UNIVERSITY OF CHICAGO   (United States)

^d BELLARIA HOSPITAL   (Italy)

Author keywords

Induction chemotherapy; Lung cancer; Morbidity; Mortality; Pulmonary resection; Radiotherapy

Indexed keywords

ADULT; ARTICLE; BRONCHOPLEURAL FISTULA; CANCER CHEMOTHERAPY; CANCER MORTALITY; CONTROLLED STUDY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; SURGICAL RISK; TERTIARY HEALTH CARE;

AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; EPIDEMIOLOGIC METHODS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PNEUMONECTOMY; PULMONARY DIFFUSING CAPACITY; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 76449116868     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.09.018     Document Type: Article

References (22)

1. Bernard A., Deschamps c, Allen M.S., Miller D.L., Trastek V.F., Jenkins G.D., and Pairolero P.C. Pneumonectomy for malignant disease: factors affecting early morbidity and mortality. J Thorac Cardiovasc Surg 121 (2001) 1076-1082
2. Licker M., Spiliopoulos A., Frey J.G., Robert J., Hohn L., Deperrot M., and Tschopp J.M. Risk factor for early mortality and major complications following pneumonectomy for non-small cell carcinoma of the lung. Chest 121 (2002) 1890-1897
3. Deslauriers J., Grégoire J., Jacques L.F., Piraux M., Guojin L., and Lacasse Y. Sleeve lobectomy vs. pneumonectomy for lung cancer: a comparative analysis of survival and sites of recurrences. Ann Thorac Surg 77 (2004) 1152-1156
4. Stamatis G. Risks of neoadjuvant chemotherapy and radiation therapy. Thorac Surg Clin 18 (2008) 71-80
5. Mansour Z., Kochetkova E.A., Ducrocq X., Vasilescu M.D., Maxant G., Buggenhout a, Whilm J.M., and Massard G. Induction chemotherapy does not increase the operative risk of pneumonectomy!. Eur J Cardiothorac Surg 32 (2007) 550
6. Depierre A., Milleron B., Moro-Sibilot D., Chevret S., Quoix E., Lebeau B., Braun D., Breton J.L., Lemarié E., Gouva S., Paillot N., Bréchot J.M., Janicot H., Lebas F.X., Terrioux P., Clavier J., Foucher P., Monchâtre M., Coëtmeur D., Level M.C., Leclerc P., Blanchon F., Rodier J.M., Thiberville L., Villeneuve A., Westeel V., Chastang C., and French Thoracic Cooperative Group. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 20 (2000) 247-253
7. Martin J., Ginsberg R.J., Abolhoda A., Bains M.S., Downey R.J., Korst R.J., Weigel T.L., Kris M.G., Venkatraman E.S., and Rusch V.W. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg 72 (2001) 1149-1154
8. Roberts J.R., Eustis C., Devore R., Carbone D., Choy H., and Johnson D. Induction chemotherapy increases perioperative complications in patients undergoing resection for non-small cell lung cancer. Ann Thorac Surg 72 (2001) 885-888
9. Doddoli C., Thomas P., Thirion X., Seree Y., Giudicelli R., and Fuentes P. Postoperative complications in relation with induction therapy for lung cancer. Eur J Cardiothorac Surg 20 (2001) 385-390
10. Brunelli A., Xiumè F., Al Refai M., Salati M., Marasco R., and Sabbatini A.G. Gemcitabine-cisplatin chemotherapy before lung resection: a case-matched analysis of early outcome. Ann Thorac Surg 81 (2006) 1963-1968
11. Colice G.L., Shafazand S., Griffin J.P., Keenan R., Bolliger CT, and American College of Chest Physicians. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 132 (2007) 161S-177S
12. Rosenbaum P.R., and Rubin D.B. The central role of the propensity score in observational studies for causal effects. Biometrika 70 (1983) 41-55
13. Blackstone E.H. Comparing apples and oranges. J Thorac Cardiovasc Surg 123 (2002) 8-15
14. Rosenbaum P.R., and Rubin D.B. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc 79 (1984) 516-524
15. Gilligan D., Nicolson M., Smith I., Groen H., Dalesio O., Goldstraw P., Hatton M., Hopwood P., Manegold C., Schramel F., Smit H., van Meerbeeck J., Nankivell M., Parmar M., Pugh C., and Stephens R. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review. Lancet 369 9577 (2007) 1903-1904
16. Fowler W.C., Langer C.J., Curran W.J., and Keller S.M. Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 55 (1993) 986-989
17. Van Schil P., Van Meerbeeck J., Kramer G., Splinter T., Legrand C., Giaccone G., Manegold C., and van Zandwijk N. Morbidity and mortality in surgery arm of EORTC 08941. Eur Respir J 26 (2005) 192-227
18. Bradley J.D., and Govindan R. Induction and adjuvant therapy for operable non-small cell lung cancer. In: Patterson G.A., Cooper J.D., Deslauriers J., Lerut A., Luketich J.D., and Rice T. (Eds). Pearson's thoracic and esophageal surgery (2008), Churchill Livingstone, Philadelphia 781-785
19. Koch C.G., Khandwala F., Nussmeier N., and Blackstone E.H. Gender and outcomes after coronary artery bypass grafting: a propensity-matched comparison. J Thorac Cardiovasc Surg 126 (2003) 2032-2043
20. Robinson L.A., Ruckdeschel J.C., Wagner H., and Stevens C.W. Treatment of non-small cell lung cancer stage IIIA. Chest 132 (2007) 243-265
21. Ma Z., Dong A., Fan J., and Cheng H. Does sleeve lobectomy concomitant with or without pulmonary artery reconstruction (double sleeve) have favorable results for non-small cell lung cancer compared with pneumonectomy? Meta analysis. Eur J Cardiothorac Surg 32 (2007) 20-28
22. Rocco G. Results of cutting-edge surgery in stage IIIA-N2 nonsmall cell lung cancer. Curr Opin Oncol 21 (2009) 105-109